AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -26.12M | -35.80M | -30.66M | -41.89M | -39.58M | |
| Free Cash Flow | -- | -26.12M | -35.80M | -30.66M | -41.89M | -39.58M | |
| Investing Cash Flow | -- | 13.91M | -50.76M | -71.20M | 3.58M | 46.07M | |
| Financing Cash Flow | -- | 75.11M | 86.47M | 34.73M | 54.87M | 86.09M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--